14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0511 $0.0700 Wednesday, 24th Apr 2024 BLPH stock ended at $0.0541. This is 7.68% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 17.21% from a day low at $0.0522 to a day high of $0.0612.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Jul 10, 2023 $0.680 $0.693 $0.669 $0.674 94 738
Jul 07, 2023 $0.680 $0.698 $0.650 $0.698 254 991
Jul 06, 2023 $0.683 $0.694 $0.681 $0.685 117 323
Jul 05, 2023 $0.700 $0.709 $0.673 $0.697 387 822
Jul 03, 2023 $0.680 $0.684 $0.671 $0.672 129 320
Jun 30, 2023 $0.680 $0.695 $0.650 $0.690 506 383
Jun 29, 2023 $0.698 $0.698 $0.659 $0.682 291 215
Jun 28, 2023 $0.740 $0.740 $0.691 $0.695 199 557
Jun 27, 2023 $0.700 $0.740 $0.670 $0.740 379 683
Jun 26, 2023 $0.709 $0.709 $0.670 $0.705 389 261
Jun 23, 2023 $0.699 $0.710 $0.686 $0.710 213 835
Jun 22, 2023 $0.700 $0.700 $0.681 $0.695 166 933
Jun 21, 2023 $0.719 $0.719 $0.682 $0.706 291 998
Jun 20, 2023 $0.710 $0.710 $0.685 $0.694 330 523
Jun 16, 2023 $0.710 $0.716 $0.684 $0.684 441 663
Jun 15, 2023 $0.718 $0.720 $0.693 $0.705 598 401
Jun 14, 2023 $0.721 $0.730 $0.702 $0.705 422 025
Jun 13, 2023 $0.723 $0.750 $0.690 $0.721 862 103
Jun 12, 2023 $0.723 $0.748 $0.691 $0.700 890 204
Jun 09, 2023 $0.767 $0.768 $0.721 $0.722 1 221 599
Jun 08, 2023 $0.798 $0.800 $0.761 $0.772 1 395 039
Jun 07, 2023 $0.88 $0.90 $0.792 $0.83 2 236 569
Jun 06, 2023 $0.92 $1.04 $0.88 $0.90 3 359 849
Jun 05, 2023 $1.30 $1.34 $0.89 $0.94 12 747 759
Jun 02, 2023 $6.87 $7.09 $6.87 $7.06 18 864
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT